Health Affairs has released the next set in its series of peer-reviewed health policy briefs on what’s shaping the U.S. market for prescription drugs, including pricing. The second set of briefs focuses on: Medicare Part B’s "buy and bill" payment structure; Medicare Part D coverage of retail drugs; Medicaid’s "best price" policy; and the Veterans Health Administration’s price negotiation model.
New Prescription Drug Policy Primers from Health Affairs
